{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:28:10Z","timestamp":1786336090252,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02400-5","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:37:37Z","timestamp":1786333057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Intersection of Androgens and Cardiovascular Disease in Postmenopausal Women"],"prefix":"10.1007","volume":"28","author":[{"given":"Michelle L.","family":"Dew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubunkola M.","family":"Olubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wang-Crocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annslee","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Elizabeth","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"6","key":"2400_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/13697137.2023.2258783","volume":"26","author":"SR Davis","year":"2023","unstructured":"Davis SR, Taylor S, Hemachandra C, Magraith K, Ebeling PR, Jane F, et al. The 2023 Practitioner\u2019s Toolkit for Managing Menopause. Climacteric. 2023;26(6):517\u201336. https:\/\/doi.org\/10.1080\/13697137.2023.2258783.","journal-title":"Climacteric"},{"issue":"2","key":"2400_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0002-9378(49)90429-9","volume":"57","author":"RB Greenblatt","year":"1949","unstructured":"Greenblatt RB, Suran RR. Indications for hormonal pellets in the therapy of endocrine and gynecic disorders. Am J Obstet Gynecol. 1949;57(2):294\u2013301. https:\/\/doi.org\/10.1016\/0002-9378(49)90429-9.","journal-title":"Am J Obstet Gynecol"},{"key":"2400_CR3","doi-asserted-by":"publisher","unstructured":"Derosa A, Testosterone. Strong Enough for a Man, but Made for a Woman. Med Res Archives. 2025;13(11). https:\/\/doi.org\/10.18103\/mra.v13i11.7106.","DOI":"10.18103\/mra.v13i11.7106"},{"key":"2400_CR4","unstructured":"Lanoff JS. JA. Testosterone in Women: Clinical Evidence and Practice Guidelines. Obstet Gynecol Clin N Am. 2026."},{"issue":"1","key":"2400_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.291.1.47","volume":"291","author":"AL Hersh","year":"2004","unstructured":"Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1):47\u201353. https:\/\/doi.org\/10.1001\/jama.291.1.47.","journal-title":"JAMA"},{"issue":"11","key":"2400_CR6","doi-asserted-by":"publisher","first-page":"CD004143","DOI":"10.1002\/14651858.CD004143.pub6","volume":"11","author":"M Bofill Rodriguez","year":"2025","unstructured":"Bofill Rodriguez M, Yong LN, Mirkov S, Bekos C, Lethaby A, Farquhar C. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2025;11(11):CD004143. https:\/\/doi.org\/10.1002\/14651858.CD004143.pub6.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2400_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","volume":"7","author":"RM Islam","year":"2019","unstructured":"Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754\u201366. https:\/\/doi.org\/10.1016\/S2213-8587(19)30189-5.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2400_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107\u201317. https:\/\/doi.org\/10.1056\/NEJMoa2215025.","journal-title":"N Engl J Med"},{"key":"2400_CR9","unstructured":"Diagnostic. and Statistical Manual of Mental Disorders, Fith Edition, Text Revision. 2013. https:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596. Accessed 13 June 2026."},{"issue":"3","key":"2400_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/13697137.2024.2339129","volume":"27","author":"RE Nappi","year":"2024","unstructured":"Nappi RE, Panay N, Davis SR. In search of a well-balanced narrative of the menopause momentum. Climacteric. 2024;27(3):223\u20135. https:\/\/doi.org\/10.1080\/13697137.2024.2339129.","journal-title":"Climacteric"},{"issue":"10430","key":"2400_CR11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0140-6736(23)02799-X","volume":"403","author":"M Hickey","year":"2024","unstructured":"Hickey M, LaCroix AZ, Doust J, Mishra GD, Sivakami M, Garlick D, et al. An empowerment model for managing menopause. Lancet. 2024;403(10430):947\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(23)02799-X.","journal-title":"Lancet"},{"issue":"4","key":"2400_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cen.15265","volume":"103","author":"YS Elhassan","year":"2025","unstructured":"Elhassan YS, Hawley JM, Cussen L, Abbara A, Clarke SA, Kempegowda P, et al. Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. Clin Endocrinol (Oxf). 2025;103(4):540\u201366. https:\/\/doi.org\/10.1111\/cen.15265.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2400_CR13","doi-asserted-by":"publisher","first-page":"105758","DOI":"10.1016\/j.phrs.2021.105758","volume":"171","author":"VE Bianchi","year":"2021","unstructured":"Bianchi VE, Bresciani E, Meanti R, Rizzi L, Omeljaniuk RJ, Torsello A. The role of androgens in women\u2019s health and wellbeing. Pharmacol Res. 2021;171:105758. https:\/\/doi.org\/10.1016\/j.phrs.2021.105758.","journal-title":"Pharmacol Res"},{"issue":"Suppl 4","key":"2400_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0015-0282(02)02985-0","volume":"77","author":"HG Burger","year":"2002","unstructured":"Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3\u20135. https:\/\/doi.org\/10.1016\/s0015-0282(02)02985-0.","journal-title":"Fertil Steril"},{"issue":"7","key":"2400_CR15","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1210\/jc.2005-0212","volume":"90","author":"SL Davison","year":"2005","unstructured":"Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847\u201353. https:\/\/doi.org\/10.1210\/jc.2005-0212.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2400_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/GME.0000000000001177","volume":"26","author":"F Labrie","year":"2019","unstructured":"Labrie F. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues. Menopause. 2019;26(2):220\u20134. https:\/\/doi.org\/10.1097\/GME.0000000000001177.","journal-title":"Menopause"},{"issue":"11","key":"2400_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.steroids.2012.05.008","volume":"77","author":"AE Campelo","year":"2012","unstructured":"Campelo AE, Cutini PH, Massheimer VL. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol. Steroids. 2012;77(11):1033\u201340. https:\/\/doi.org\/10.1016\/j.steroids.2012.05.008.","journal-title":"Steroids"},{"issue":"1","key":"2400_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/13697137.2023.2250252","volume":"27","author":"SR Davis","year":"2024","unstructured":"Davis SR. Testosterone and the heart: friend or foe? Climacteric. 2024;27(1):53\u20139. https:\/\/doi.org\/10.1080\/13697137.2023.2250252.","journal-title":"Climacteric"},{"issue":"1","key":"2400_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.mca.0000236290.79306.d1","volume":"18","author":"T Montalcini","year":"2007","unstructured":"Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis. 2007;18(1):9\u201313. https:\/\/doi.org\/10.1097\/01.mca.0000236290.79306.d1.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"2400_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41371-021-00576-7","volume":"36","author":"PJ Connelly","year":"2022","unstructured":"Connelly PJ, Casey H, Montezano AC, Touyz RM, Delles C. Sex steroids receptors, hypertension, and vascular ageing. J Hum Hypertens. 2022;36(2):120\u20135. https:\/\/doi.org\/10.1038\/s41371-021-00576-7.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"2400_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ejendo\/lvaf032","volume":"192","author":"IJ Chen","year":"2025","unstructured":"Chen IJ, Stanczyk FZ, Sriprasert I, Karim R, Shoupe D, Kono N, et al. Sex steroid hormones and subclinical atherosclerosis progression in postmenopausal women. Eur J Endocrinol. 2025;192(3):248\u201356. https:\/\/doi.org\/10.1093\/ejendo\/lvaf032.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2400_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/GME.0000000000002192","volume":"30","author":"IJ Chen","year":"2023","unstructured":"Chen IJ, Shoupe D, Karim R, Stanczyk FZ, Kono N, Sriprasert I, et al. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women. Menopause. 2023;30(7):692\u2013702. https:\/\/doi.org\/10.1097\/GME.0000000000002192.","journal-title":"Menopause"},{"issue":"12","key":"2400_CR23","doi-asserted-by":"publisher","first-page":"e1515","DOI":"10.1210\/clinem\/dgad388","volume":"108","author":"DS Lopez","year":"2023","unstructured":"Lopez DS, Mulla JS, El Haddad D, Tahashilder MI, Polychronopolou E, Baillargeon J, et al. Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People. J Clin Endocrinol Metab. 2023;108(12):e1515\u201323. https:\/\/doi.org\/10.1210\/clinem\/dgad388.","journal-title":"J Clin Endocrinol Metab"},{"key":"2400_CR24","doi-asserted-by":"publisher","first-page":"8849641","DOI":"10.1155\/2020\/8849641","volume":"2020","author":"A Carbajal-Garcia","year":"2020","unstructured":"Carbajal-Garcia A, Reyes-Garcia J, Montano LM. Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes. Int J Endocrinol. 2020;2020:8849641. https:\/\/doi.org\/10.1155\/2020\/8849641.","journal-title":"Int J Endocrinol"},{"issue":"9","key":"2400_CR25","doi-asserted-by":"publisher","first-page":"100882","DOI":"10.1016\/j.cpcardiol.2021.100882","volume":"47","author":"G Gutierrez","year":"2022","unstructured":"Gutierrez G, Wamboldt R, Baranchuk A. The Impact of Testosterone on the QT Interval: A Systematic Review. Curr Probl Cardiol. 2022;47(9):100882. https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100882.","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"2400_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/13697137.2024.2310530","volume":"27","author":"SR Davis","year":"2024","unstructured":"Davis SR, Azene ZN, Tonkin AM, Woods RL, McNeil JJ, Islam RM. Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study. Climacteric. 2024;27(3):282\u20138. https:\/\/doi.org\/10.1080\/13697137.2024.2310530.","journal-title":"Climacteric"},{"issue":"2","key":"2400_CR27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1210\/jc.2004-0744","volume":"90","author":"S Mudali","year":"2005","unstructured":"Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH, et al. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2005;90(2):1202\u20139. https:\/\/doi.org\/10.1210\/jc.2004-0744.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2400_CR28","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2009-0740","volume":"94","author":"SM Patel","year":"2009","unstructured":"Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2009;94(12):4776\u201384. https:\/\/doi.org\/10.1210\/jc.2009-0740.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2400_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1210\/clinem\/dgac673","volume":"108","author":"AL Hirschberg","year":"2023","unstructured":"Hirschberg AL. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman. J Clin Endocrinol Metab. 2023;108(5):1243\u201353. https:\/\/doi.org\/10.1210\/clinem\/dgac673.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2400_CR30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288\u201399. https:\/\/doi.org\/10.1001\/jama.295.11.1288.","journal-title":"JAMA"},{"issue":"1","key":"2400_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.13862","volume":"90","author":"MW O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly MW, Glisic M, Kumarendran B, Subramanian A, Manolopoulos KN, Tahrani AA, et al. Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort. Clin Endocrinol (Oxf). 2019;90(1):145\u201354. https:\/\/doi.org\/10.1111\/cen.13862.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2400_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/16652681.1235481","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Upala S, Testosterone. Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. Ann Hepatol. 2017;16(3):382\u201394. https:\/\/doi.org\/10.5604\/16652681.1235481.","journal-title":"Ann Hepatol"},{"issue":"2","key":"2400_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0751-5.","journal-title":"Nat Med"},{"issue":"1","key":"2400_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1373\/clinchem.2013.207217","volume":"60","author":"A Goto","year":"2014","unstructured":"Goto A, Chen BH, Song Y, Cauley J, Cummings SR, Farhat GN, et al. Age, body mass, usage of exogenous estrogen, and lifestyle factors in relation to circulating sex hormone-binding globulin concentrations in postmenopausal women. Clin Chem. 2014;60(1):174\u201385. https:\/\/doi.org\/10.1373\/clinchem.2013.207217.","journal-title":"Clin Chem"},{"issue":"6","key":"2400_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/cen.12768","volume":"83","author":"LA Cooper","year":"2015","unstructured":"Cooper LA, Page ST, Amory JK, Anawalt BD, Matsumoto AM. The association of obesity with sex hormone-binding globulin is stronger than the association with ageing\u2013implications for the interpretation of total testosterone measurements. Clin Endocrinol (Oxf). 2015;83(6):828\u201333. https:\/\/doi.org\/10.1111\/cen.12768.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2400_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.metabol.2008.02.012","volume":"57","author":"MA Maturana","year":"2008","unstructured":"Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism. 2008;57(7):961\u20135. https:\/\/doi.org\/10.1016\/j.metabol.2008.02.012.","journal-title":"Metabolism"},{"issue":"4","key":"2400_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1530\/EC-20-0080","volume":"9","author":"F Schederecker","year":"2020","unstructured":"Schederecker F, Cecil A, Prehn C, Nano J, Koenig W, Adamski J, et al. Sex hormone-binding globulin, androgens and mortality: the KORA-F4 cohort study. Endocr Connect. 2020;9(4):326\u201336. https:\/\/doi.org\/10.1530\/EC-20-0080.","journal-title":"Endocr Connect"},{"issue":"5","key":"2400_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/EJE-20-1253","volume":"184","author":"J Wang","year":"2021","unstructured":"Wang J, Fan X, Yang M, Song M, Wang K, Giovannucci E, et al. Sex-specific associations of circulating testosterone levels with all-cause and cause-specific mortality. Eur J Endocrinol. 2021;184(5):723\u201332. https:\/\/doi.org\/10.1530\/EJE-20-1253.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2400_CR39","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S2666-7568(22)00001-0","volume":"3","author":"RM Islam","year":"2022","unstructured":"Islam RM, Bell RJ, Handelsman DJ, McNeil JJ, Nelson MR, Reid CM, et al. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022;3(2):e109\u201318. https:\/\/doi.org\/10.1016\/S2666-7568(22)00001-0.","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"2400_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/EJE-10-0307","volume":"163","author":"C Sievers","year":"2010","unstructured":"Sievers C, Klotsche J, Pieper L, Schneider HJ, Marz W, Wittchen HU, et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol. 2010;163(4):699\u2013708. https:\/\/doi.org\/10.1530\/EJE-10-0307.","journal-title":"Eur J Endocrinol"},{"key":"2400_CR41","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.ajpc.2023.100479","volume":"14","author":"YA Kwapong","year":"2023","unstructured":"Kwapong YA, Sharma G, Valero-Elizondo J, Achirica MC, Ali SS, Blaha MJ, et al. The association of sex-specific hormones with coronary artery plaque characteristics from Miami Heart (MiHeart) study. Am J Prev Cardiol. 2023;14:100479. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100479.","journal-title":"Am J Prev Cardiol"},{"issue":"2","key":"2400_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/ATVBAHA.114.304821","volume":"35","author":"M Benn","year":"2015","unstructured":"Benn M, Voss SS, Holmegard HN, Jensen GB, Tybjaerg-Hansen A, Nordestgaard BG. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arterioscler Thromb Vasc Biol. 2015;35(2):471\u20137. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304821.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"2400_CR43","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","volume":"71","author":"D Zhao","year":"2018","unstructured":"Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, et al. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women. J Am Coll Cardiol. 2018;71(22):2555\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.083.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2400_CR44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1210\/jc.2009-1693","volume":"95","author":"GA Laughlin","year":"2010","unstructured":"Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab. 2010;95(2):740\u20137. https:\/\/doi.org\/10.1210\/jc.2009-1693.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2400_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ijir.2009.64","volume":"22","author":"JS Brand","year":"2010","unstructured":"Brand JS, van der Schouw YT, Testosterone. SHBG and cardiovascular health in postmenopausal women. Int J Impot Res. 2010;22(2):91\u2013104. https:\/\/doi.org\/10.1038\/ijir.2009.64.","journal-title":"Int J Impot Res"},{"issue":"3","key":"2400_CR46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ejhf.3189","volume":"26","author":"J Lim","year":"2024","unstructured":"Lim J, Hashemian M, Blechter B, Roger VL, Wong JYY. Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank. Eur J Heart Fail. 2024;26(3):540\u201350. https:\/\/doi.org\/10.1002\/ejhf.3189.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2400_CR47","doi-asserted-by":"publisher","first-page":"e3798","DOI":"10.1210\/clinem\/dgaa500","volume":"105","author":"D Zhao","year":"2020","unstructured":"Zhao D, Guallar E, Ballantyne CM, Post WS, Ouyang P, Vaidya D, et al. Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab. 2020;105(10):e3798\u2013807. https:\/\/doi.org\/10.1210\/clinem\/dgaa500.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2400_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/2047487318778346","volume":"25","author":"T Zeller","year":"2018","unstructured":"Zeller T, Schnabel RB, Appelbaum S, Ojeda F, Berisha F, Schulte-Steinberg B, et al. Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women - results from the FINRISK study. Eur J Prev Cardiol. 2018;25(11):1133\u20139. https:\/\/doi.org\/10.1177\/2047487318778346.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"2400_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ijc.33555","volume":"149","author":"EL Watts","year":"2021","unstructured":"Watts EL, Perez-Cornago A, Knuppel A, Tsilidis KK, Key TJ, Travis RC. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank. Int J Cancer. 2021;149(3):573\u201384. https:\/\/doi.org\/10.1002\/ijc.33555.","journal-title":"Int J Cancer"},{"key":"2400_CR50","doi-asserted-by":"publisher","first-page":"1161356","DOI":"10.3389\/fendo.2023.1161356","volume":"14","author":"B Zhao","year":"2023","unstructured":"Zhao B, Wang Z, Liu D, Zhang S. Genetically predicted serum testosterone and risk of gynecological disorders: a Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1161356. https:\/\/doi.org\/10.3389\/fendo.2023.1161356.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2400_CR51","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41416-021-01518-3","volume":"125","author":"A Mullee","year":"2021","unstructured":"Mullee A, Dimou N, Allen N, O\u2019Mara T, Gunter MJ, Murphy N. Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses. Br J Cancer. 2021;125(9):1308\u201317. https:\/\/doi.org\/10.1038\/s41416-021-01518-3.","journal-title":"Br J Cancer"},{"issue":"1","key":"2400_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41416-021-01392-z","volume":"125","author":"S Tin Tin","year":"2021","unstructured":"Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. Br J Cancer. 2021;125(1):126\u201334. https:\/\/doi.org\/10.1038\/s41416-021-01392-z.","journal-title":"Br J Cancer"},{"issue":"5","key":"2400_CR53","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/jsxmed\/qdae032","volume":"21","author":"P Agrawal","year":"2024","unstructured":"Agrawal P, Singh SM, Hsueh J, Grutman A, An C, Able C, et al. Testosterone therapy in females is not associated with increased cardiovascular or breast cancer risk: a claims database analysis. J Sex Med. 2024;21(5):414\u20139. https:\/\/doi.org\/10.1093\/jsxmed\/qdae032.","journal-title":"J Sex Med"},{"issue":"8","key":"2400_CR54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/NEJMcp2313307","volume":"391","author":"SR Davis","year":"2024","unstructured":"Davis SR. Sexual Dysfunction in Women. N Engl J Med. 2024;391(8):736\u201345. https:\/\/doi.org\/10.1056\/NEJMcp2313307.","journal-title":"N Engl J Med"},{"issue":"3","key":"2400_CR55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00737-024-01513-6","volume":"28","author":"S Glynne","year":"2025","unstructured":"Glynne S, Kamal A, Kamel AM, Reisel D, Newson L. Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study. Arch Womens Ment Health. 2025;28(3):541\u201350. https:\/\/doi.org\/10.1007\/s00737-024-01513-6.","journal-title":"Arch Womens Ment Health"},{"key":"2400_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2022.11.001","volume":"168","author":"C Hemachandra","year":"2023","unstructured":"Hemachandra C, Islam RM, Bell RJ, Sultana F, Davis SR. The association between testosterone and depression in postmenopausal women: A systematic review of observational studies. Maturitas. 2023;168:62\u201370. https:\/\/doi.org\/10.1016\/j.maturitas.2022.11.001.","journal-title":"Maturitas"},{"issue":"10","key":"2400_CR57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1176\/appi.ajp.2020.19080844","volume":"177","author":"LE Dichtel","year":"2020","unstructured":"Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, et al. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. Am J Psychiatry. 2020;177(10):965\u201373. https:\/\/doi.org\/10.1176\/appi.ajp.2020.19080844.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"2400_CR58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/GME.0000000000002190","volume":"30","author":"SJ Parish","year":"2023","unstructured":"Parish SJ, Kling JM. Testosterone use for hypoactive sexual desire disorder in postmenopausal women. Menopause. 2023;30(7):781\u20133. https:\/\/doi.org\/10.1097\/GME.0000000000002190.","journal-title":"Menopause"},{"key":"2400_CR59","doi-asserted-by":"publisher","unstructured":"Donovitz GS A Personal Prospective on Testosterone Therapy in Women-What We Know in 2022. J Pers Med. 2022;12(8). . https:\/\/doi.org\/10.3390\/jpm12081194.","DOI":"10.3390\/jpm12081194"},{"issue":"6","key":"2400_CR60","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/13697137.2025.2585487","volume":"28","author":"N Panay","year":"2025","unstructured":"Panay N, Fenton A, Hamoda H, Hillard T, Islam R, Pedder H, et al. International Menopause Society (IMS) recommendations and key messages on women\u2019s midlife health and menopause. Climacteric. 2025;28(6):634\u201356. https:\/\/doi.org\/10.1080\/13697137.2025.2585487.","journal-title":"Climacteric"},{"key":"2400_CR61","unstructured":"BMS Management of the Menopause. British Menopause Society. 7th ed., vol 12026. p. 7."},{"key":"2400_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/tre.70016","volume":"16","author":"A WACPS-H","year":"2025","unstructured":"WACPS-H A. Testosterone Replacement, Where Are We in 2025? Trends Urol Men\u2019s Health. 2025;16:1\u201310. https:\/\/doi.org\/10.1002\/tre.70016","journal-title":"Trends Urol Men\u2019s Health"},{"issue":"10","key":"2400_CR63","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1210\/jc.2019-01603","volume":"104","author":"SR Davis","year":"2019","unstructured":"Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660\u20136. https:\/\/doi.org\/10.1210\/jc.2019-01603.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2400_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/sxmrev\/qeae062","volume":"13","author":"I Goldstein","year":"2025","unstructured":"Goldstein I, Chidambaram N, Dobs A, King S, Miner M, Ramasamy R, et al. Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2025;13(1):33\u201340. https:\/\/doi.org\/10.1093\/sxmrev\/qeae062.","journal-title":"Sex Med Rev"},{"issue":"12","key":"2400_CR65","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jcem.85.12.7045","volume":"85","author":"RS Swerdloff","year":"2000","unstructured":"Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000;85(12):4500\u201310. https:\/\/doi.org\/10.1210\/jcem.85.12.7045.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2400_CR66","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1210\/clinem\/dgab772","volume":"107","author":"MG Figueiredo","year":"2022","unstructured":"Figueiredo MG, Gagliano-Juca T, Basaria S. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option. J Clin Endocrinol Metab. 2022;107(3):614\u201326. https:\/\/doi.org\/10.1210\/clinem\/dgab772.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2400_CR67","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/JU.0000000000002301","volume":"207","author":"EJ Choi","year":"2022","unstructured":"Choi EJ, Xu P, Barham D, El-Khatib FM, Yafi FA, Kavoussi PK. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. J Urol. 2022;207(3):677\u201383. https:\/\/doi.org\/10.1097\/JU.0000000000002301.","journal-title":"J Urol"},{"issue":"2","key":"2400_CR68","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1743-6109.2011.02570.x","volume":"9","author":"AR McCullough","year":"2012","unstructured":"McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel((R))) insertion. J Sex Med. 2012;9(2):594\u2013601. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02570.x.","journal-title":"J Sex Med"},{"issue":"9","key":"2400_CR69","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/jwh.2011.3444","volume":"21","author":"T Sedlak","year":"2012","unstructured":"Sedlak T, Shufelt C, Iribarren C, Merz CN. Sex hormones and the QT interval: a review. J Womens Health (Larchmt). 2012;21(9):933\u201341. https:\/\/doi.org\/10.1089\/jwh.2011.3444.","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"2400_CR70","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2017-00025","volume":"38","author":"AL Goldman","year":"2017","unstructured":"Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone\u2019s Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. 2017;38(4):302\u201324. https:\/\/doi.org\/10.1210\/er.2017-00025.","journal-title":"Endocr Rev"},{"issue":"1","key":"2400_CR71","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1210\/jcem.86.1.7103","volume":"86","author":"S Worboys","year":"2001","unstructured":"Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab. 2001;86(1):158\u201361. https:\/\/doi.org\/10.1210\/jcem.86.1.7103.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2400_CR72","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","volume":"3","author":"SR Davis","year":"2015","unstructured":"Davis SR, Wahlin-Jacobsen S. Testosterone in women\u2013the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980\u201392. https:\/\/doi.org\/10.1016\/S2213-8587(15)00284-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2400_CR73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/13697131003675922","volume":"13","author":"N Panay","year":"2010","unstructured":"Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric. 2010;13(2):121\u201331. https:\/\/doi.org\/10.3109\/13697131003675922.","journal-title":"Climacteric"},{"issue":"2","key":"2400_CR74","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/andr.13367","volume":"11","author":"G Corona","year":"2023","unstructured":"Corona G, Vena W, Pizzocaro A, Vignozzi L, Sforza A, Maggi M. Testosterone therapy in diabetes and pre-diabetes. Andrology. 2023;11(2):204\u201314. https:\/\/doi.org\/10.1111\/andr.13367.","journal-title":"Andrology"},{"key":"2400_CR75","doi-asserted-by":"publisher","first-page":"1789504","DOI":"10.3389\/fendo.2026.1789504","volume":"17","author":"D Viana","year":"2026","unstructured":"Viana D, Camara LC, Alto LSM. Cardiovascular mortality associated with testosterone therapy in cisgender women and transgender men: a systematic review. Front Endocrinol (Lausanne). 2026;17:1789504. https:\/\/doi.org\/10.3389\/fendo.2026.1789504.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2400_CR76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7326\/0003-4819-148-8-200804150-00001","volume":"148","author":"S Davis","year":"2008","unstructured":"Davis S, Papalia MA, Norman RJ, O\u2019Neill S, Redelman M, Williamson M, et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med. 2008;148(8):569\u201377. https:\/\/doi.org\/10.7326\/0003-4819-148-8-200804150-00001.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2400_CR77","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/eje.1.02065","volume":"154","author":"LM Leao","year":"2006","unstructured":"Leao LM, Duarte MP, Silva DM, Bahia PR, Coeli CM, de Farias ML. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study. Eur J Endocrinol. 2006;154(1):131\u20139. https:\/\/doi.org\/10.1530\/eje.1.02065.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2400_CR78","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.cjca.2022.09.018","volume":"38","author":"AK Lucas-Herald","year":"2022","unstructured":"Lucas-Herald AK, Touyz RM. Androgens and Androgen Receptors as Determinants of Vascular Sex Differences Across the Lifespan. Can J Cardiol. 2022;38(12):1854\u201364. https:\/\/doi.org\/10.1016\/j.cjca.2022.09.018.","journal-title":"Can J Cardiol"},{"issue":"25","key":"2400_CR79","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020;142(25):e506\u201332. https:\/\/doi.org\/10.1161\/CIR.0000000000000912.","journal-title":"Circulation"},{"issue":"8","key":"2400_CR80","doi-asserted-by":"publisher","first-page":"e0309160","DOI":"10.1371\/journal.pone.0309160","volume":"19","author":"S Selinger","year":"2024","unstructured":"Selinger S, Thallapureddy A. Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018\u20132022. PLoS ONE. 2024;19(8):e0309160. https:\/\/doi.org\/10.1371\/journal.pone.0309160.","journal-title":"PLoS ONE"},{"issue":"19","key":"2400_CR81","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/CIR.0000000000001139","volume":"147","author":"LS Mehta","year":"2023","unstructured":"Mehta LS, Velarde GP, Lewey J, Sharma G, Bond RM, Navas-Acien A, et al. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association. Circulation. 2023;147(19):1471\u201387. https:\/\/doi.org\/10.1161\/CIR.0000000000001139.","journal-title":"Circulation"},{"key":"2400_CR82","unstructured":"US Census Bureau. Age and Sex Composition in the United States.: https:\/\/www.census.gov\/topics\/population\/age-and-sex.html. Accessed 22 May 2026."},{"issue":"7","key":"2400_CR83","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/j.1743-6109.2009.01294.x","volume":"6","author":"MC Snabes","year":"2009","unstructured":"Snabes MC, Simes SM. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med. 2009;6(7):1846\u20139. https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01294.x.","journal-title":"J Sex Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02400-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:37:39Z","timestamp":1786333059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02400-5","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"28 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The views expressed in this presentation reflect the results of research conducted by the author(s) and do not necessarily reflect the official policy or position of the Defense Health Agency, the Department of Veterans Affairs, Department of Defense, nor the U.S. Government.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"77"}}